| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e88b5bdcc77f65ae734ebaacffeef1ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_eb9c6b40161bafe7bd55f0b4defcea04 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-505 |
| filingDate |
2017-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bde186414462c030156b606cd75b9489
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a95e29460c4711237b7974168236de6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da89c63b43b387f099bde626085bf296
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0e7f98a0beae1e2fbff87eb281df08d |
| publicationDate |
2018-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201803594-A |
| titleOfInvention |
Method for using HDAC inhibitor and BET inhibitor and pharmaceutical combination |
| abstract |
The present invention relates to a pharmaceutical combination comprising a HDAC6 selective inhibitor and a BET inhibitor for use in treating cancer in a subject in need thereof. The invention also provides methods for treating cancer in an individual in need, the methods comprising administering to the individual effective amounts of a HDAC6 selective inhibitor and a BET inhibitor. |
| priorityDate |
2016-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |